Similar articles

• Thrombopoietin (Mpl ligand) and the regulation of platelet production.

  Cohen-Solal K, Debili N, Vainchenker W, Wendling F. Cohen-Solal K, et al. Eur Cytokine Netw. 1997 Sep;8(3):311-4. Eur Cytokine Netw. 1997. PMID: 9346371 Review. No abstract available.
• Thrombopoietin: past, present and future.

  Evatt BL, Kellar KL, Ramsey RB. Evatt BL, et al. Prog Clin Biol Res. 1986;215:143-55. Prog Clin Biol Res. 1986. PMID: 3523520 Review. No abstract available.
• Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.

  Horie K, Miyazaki H, Hagiwara T, Tahara E, Matsumoto A, Kadoya T, Ogami K, Kato T. Horie K, et al. Exp Hematol. 1997 Feb;25(2):169-76. Exp Hematol. 1997. PMID: 9015217
• Regulation of platelet production: the normal response to perturbation and cyclical platelet disease.

  Santillán M, Mahaffy JM, Bélair J, Mackey MC. Santillán M, et al. J Theor Biol. 2000 Oct 21;206(4):585-603. doi: 10.1006/jtbi.2000.2149. J Theor Biol. 2000. PMID: 11013116
• AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist.

  Fukushima-Shintani M, Suzuki K, Iwatsuki Y, Abe M, Sugasawa K, Hirayama F, Kawasaki T, Nakahata T. Fukushima-Shintani M, et al. Eur J Haematol. 2009 Apr;82(4):247-54. doi: 10.1111/j.1600-0609.2008.01198.x. Epub 2009 Jan 16. Eur J Haematol. 2009. PMID: 19183407